After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Pfizer's $14 billion acquisition of Medivation is a strong purchase, according to Jim Cramer, who now wonders what Sanofi will do next.
Cramer shares his views on the winners and losers of this earnings season. Comcast, Idexx Laboratories and Zoetis are among the stocks discussed.
Trade-Ideas LLC identified Regeneron Pharmaceuticals (REGN) as an unusual social activity candidate
With enough of earnings season now under our belt, we check out the promising themes and the sectors to avoid.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.